Effects of Dietary Polyphenols and ω-3 Fatty Acids on Cardiovascular Risk Factors in High Risk Subjects (Etherpaths)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01154478 |
Recruitment Status :
Completed
First Posted : July 1, 2010
Last Update Posted : June 19, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Metabolic Syndrome | Other: Diet rich in omega-3 fatty acids Other: Diet rich in polyphenols Other: Control diet Other: diet rich in omega-3 and polyphenols | Not Applicable |
Fish consumption is associated with a lower cardiovascular risk and dietary supplementation with ω-3 fatty acids reduces plasma triglyceride levels. The mechanisms of action of ω-3 fatty acids are currently not completely understood. It has been hypothesized that polyunsaturated ω-3 fatty acids beneficial effects may be mediated through their ability to facilitate plasmalogen replenishment.
Polyphenols are associated with beneficial effects on some cardiovascular risk factors, in particular with a reduced lipid oxidation. Less data are available on their effects on lipid metabolism. Recent data suggest that these effects could be mediated by changes in plasmalogen levels.
The effects on lipid metabolism of combining the two dietary approaches (ω-3 fatty acids and polyphenols) are not known.
While developed populations live for the most part in the postprandial state, much of the information on lipid metabolism refers to fasting condition.
Dietary Intervention Study Design
Eighty people at high cardiovascular risk randomly assigned to one of the four different nutritional 8-week interventions:
(A) Control diet poor in omega-3 fatty acids and polyphenols (B) Diet rich in omega-3 fatty acids (C) Diet rich in polyphenols (D) Diet rich in omega-3 fatty acids and polyphenols
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 86 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Effects of Polyphenols and Omega-3 Fatty Acids on Cardiovascular Rik Factors (Focusing on Postprandial Lipids Metabolism) in Subjects With High Risk for Type 2 Diabetes and Cardiovascular Diseases |
Study Start Date : | January 2010 |
Actual Primary Completion Date : | June 2012 |
Actual Study Completion Date : | June 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: B group
Diet rich in omega-3 fatty acids
|
Other: Diet rich in omega-3 fatty acids
fish at least 3 times per week, large leaf vegetables |
Experimental: C group
Diet rich in polyphenols
|
Other: Diet rich in polyphenols
extra virgin olive oil, green tea, berries,fruits rich in polyphenols, dark chocolate, decaffenated coffee |
Experimental: D group
Diet rich in polyphenols and in omega-3 fatty acids
|
Other: diet rich in omega-3 and polyphenols
Fish at least 3 times x week,large leaf vegetables + extra virgin olive oil, green tea, berries,fruits rich in polyphenols, dark chocolate, decaffenated coffee |
Placebo Comparator: A group (control group)
diet with low content of omega-3 fatty acids and polyphenols
|
Other: Control diet
low content of omega-3 fatty acids and polyphenols (low intake of fish, nuts and legumes,oil rich in monounsaturated fatty acids, vegetables and fruits poor in polyphenols) |
- incremental AUC after a test meal of triglycerides concentration in chylomicrons and VLDL fraction [ Time Frame: 48 months ]
- insulin sensitivity [ Time Frame: 48 months ]
- plasma and adipose tissue adipokines [ Time Frame: 48 months ]
- endothelial function [ Time Frame: 48 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- bmi >25<35 kg/m2
- High waist circumference (men >102 cm, women >88 cm) + one the following components of metabolic syndrome :
Fasting plasma triglycerides ≥150 mg/dl Fasting HDL-col <40 mg/dl (men) and <50 mg/dl (women) Fasting plasma glucose 100-125 mg/dl
Exclusion Criteria:
- Fasting plasma triglycerides ≥400 mg/dl and cholesterol >270 mg/dl
- Cardiovascular events (AMI and/or stroke) in the last 6 months
- Diabetes mellitus
- Regular intensive physical activity
- Kidney (serum creatinine >1.7 mg/dl) and liver (transaminases >double)
- Hypolipidemic or antinflammatory drugs
- Anemia (Hb <12 g/dl) or any other chronic disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154478
Italy | |
Federico II University | |
Napoli, Naples, Italy, 80131 |
Study Director: | Giovanni Annuzzi | Federico II University |
Responsible Party: | rivellese angela, Associate Professor, Federico II University |
ClinicalTrials.gov Identifier: | NCT01154478 |
Other Study ID Numbers: |
EpWP5 |
First Posted: | July 1, 2010 Key Record Dates |
Last Update Posted: | June 19, 2013 |
Last Verified: | June 2013 |
polyphenols omega-3 postprandial lipemia adipose tissue |
Metabolic Syndrome Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |